Ann‐Kathrin Eisfeld
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Hematology 43
- Acute Myeloid Leukemia Research 40
- Chronic Myeloid Leukemia Treatments 11
- Multiple Myeloma Research and Treatments 6
-
- Histone Deacetylase Inhibitors Research 10
- Co-authors
- Clara D. Bloomfield (26 shared papers)Richard M. Stone (28 shared papers)Jessica Kohlschmidt (29 shared papers)Deedra Nicolet (29 shared papers)Krzysztof Mrózek (32 shared papers)Jonathan E. Kolitz (25 shared papers)Andrew J. Carroll (22 shared papers)John C. Byrd (28 shared papers)
- Journals
- Blood (20 papers)Leukemia (7 papers)Blood Advances (5 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Ann‐Kathrin Eisfeld
59 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Hematology 581
- Cancer Research 274
- Genetics 181
- Molecular Biology 482
- Public Health, Environmental and Occupational Health 130
Countries citing papers authored by Ann‐Kathrin Eisfeld
This map shows the geographic impact of Ann‐Kathrin Eisfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Kathrin Eisfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Kathrin Eisfeld more than expected).
Fields of papers citing papers by Ann‐Kathrin Eisfeld
This network shows the impact of papers produced by Ann‐Kathrin Eisfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Kathrin Eisfeld. The network helps show where Ann‐Kathrin Eisfeld may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann‐Kathrin Eisfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 141 | |
| 2 | 2018 | 73 | |
| 3 | 2022 | 67 | |
| 4 | 2018 | 66 | |
| 5 | 2020 | 61 | |
| 6 | 2020 | 56 | |
| 7 | 2019 | 53 | |
| 8 | 2016 | 52 | |
| 9 | 2016 | 42 | |
| 10 | 2019 | 37 | |
| 11 | 2023 | 35 | |
| 12 | 2018 | 32 | |
| 13 | 2015 | 31 | |
| 14 | 2014 | 30 | |
| 15 | 2014 | 27 | |
| 16 | 2022 | 23 | |
| 17 | 2020 | 22 | |
| 18 | 2012 | 20 | |
| 19 | 2015 | 18 | |
| 20 | 2017 | 17 |
About Ann‐Kathrin Eisfeld
Ann‐Kathrin Eisfeld is a scholar working on Hematology, Molecular Biology, Cancer Research, Genetics and Public Health, Environmental and Occupational Health, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (40 papers), Chronic Myeloid Leukemia Treatments (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Histone Deacetylase Inhibitors Research (10 papers), Cancer Genomics and Diagnostics (9 papers), Multiple Myeloma Research and Treatments (6 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Hematology (581 citations), Cancer Research (274 citations), Genetics (181 citations), Molecular Biology (482 citations) and Public Health, Environmental and Occupational Health (130 citations). Ann‐Kathrin Eisfeld has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Clara D. Bloomfield, Richard M. Stone, Jessica Kohlschmidt, Deedra Nicolet, Krzysztof Mrózek, Jonathan E. Kolitz, Andrew J. Carroll, John C. Byrd, Bayard L. Powell and James S. Blachly. Their work appears in journals such as Blood, Leukemia, Blood Advances, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.